Antibiotic-resistant bacterial infections are difficult to treat, producing a burden on healthcare and the economy. Extraintestinal pathogenic Escherichia coli (ExPEC) strains frequently carry antibiotic resistance genes, cause infections outside of the intestine, and are causative agents of hospital-acquired infections. Developing a prevention strategy against this pathogen is challenging due to its antibiotic resistance and antigenic diversity. E.
Download count: 0
Details
- Maddux, Jacob (Contributor)
- Stromberg, Zachary R. (Author)
- Curtiss, Roy (Contributor)
- Mellata, Melha (Contributor)
- Biodesign Institute (Contributor)
- 2017-10-09
- Digital object identifier: 10.3389/fimmu.2017.01280
- Identifier TypeInternational standard serial numberIdentifier Value1664-3224
- View the article as published at https://www.frontiersin.org/articles/10.3389/fimmu.2017.01280/full, opens in a new window
Citation and reuse
Cite this item
This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.
Maddux, J. T., Stromberg, Z. R., Iii, R. C., & Mellata, M. (2017). Evaluation of Recombinant Attenuated Salmonella Vaccine Strains for Broad Protection against Extraintestinal Pathogenic Escherichia coli. Frontiers in Immunology, 8. doi:10.3389/fimmu.2017.01280